783 related articles for article (PubMed ID: 18310473)
1. Modulation of monoamine transporters by common biogenic amines via trace amine-associated receptor 1 and monoamine autoreceptors in human embryonic kidney 293 cells and brain synaptosomes.
Xie Z; Westmoreland SV; Miller GM
J Pharmacol Exp Ther; 2008 May; 325(2):629-40. PubMed ID: 18310473
[TBL] [Abstract][Full Text] [Related]
2. Beta-phenylethylamine alters monoamine transporter function via trace amine-associated receptor 1: implication for modulatory roles of trace amines in brain.
Xie Z; Miller GM
J Pharmacol Exp Ther; 2008 May; 325(2):617-28. PubMed ID: 18182557
[TBL] [Abstract][Full Text] [Related]
3. Rhesus monkey trace amine-associated receptor 1 signaling: enhancement by monoamine transporters and attenuation by the D2 autoreceptor in vitro.
Xie Z; Westmoreland SV; Bahn ME; Chen GL; Yang H; Vallender EJ; Yao WD; Madras BK; Miller GM
J Pharmacol Exp Ther; 2007 Apr; 321(1):116-27. PubMed ID: 17234900
[TBL] [Abstract][Full Text] [Related]
4. Normal thermoregulatory responses to 3-iodothyronamine, trace amines and amphetamine-like psychostimulants in trace amine associated receptor 1 knockout mice.
Panas HN; Lynch LJ; Vallender EJ; Xie Z; Chen GL; Lynn SK; Scanlan TS; Miller GM
J Neurosci Res; 2010 Jul; 88(9):1962-9. PubMed ID: 20155805
[TBL] [Abstract][Full Text] [Related]
5. The extracts of Fructus Akebiae, a preparation containing 90% of the active ingredient hederagenin: serotonin, norepinephrine and dopamine reuptake inhibitor.
Jin ZL; Gao N; Zhou D; Chi MG; Yang XM; Xu JP
Pharmacol Biochem Behav; 2012 Jan; 100(3):431-9. PubMed ID: 22005599
[TBL] [Abstract][Full Text] [Related]
6. Interaction of the anorectic medication, phendimetrazine, and its metabolites with monoamine transporters in rat brain.
Rothman RB; Katsnelson M; Vu N; Partilla JS; Dersch CM; Blough BE; Baumann MH
Eur J Pharmacol; 2002 Jun; 447(1):51-7. PubMed ID: 12106802
[TBL] [Abstract][Full Text] [Related]
7. Interaction of psychoactive tryptamines with biogenic amine transporters and serotonin receptor subtypes.
Blough BE; Landavazo A; Decker AM; Partilla JS; Baumann MH; Rothman RB
Psychopharmacology (Berl); 2014 Oct; 231(21):4135-44. PubMed ID: 24800892
[TBL] [Abstract][Full Text] [Related]
8. A receptor mechanism for methamphetamine action in dopamine transporter regulation in brain.
Xie Z; Miller GM
J Pharmacol Exp Ther; 2009 Jul; 330(1):316-25. PubMed ID: 19364908
[TBL] [Abstract][Full Text] [Related]
9. The Role of Biogenic Amine Transporters in Trace Amine-Associated Receptor 1 Regulation of Methamphetamine-Induced Neurotoxicity.
Miner NB; Phillips TJ; Janowsky A
J Pharmacol Exp Ther; 2019 Oct; 371(1):36-44. PubMed ID: 31320495
[TBL] [Abstract][Full Text] [Related]
10. Taar1-mediated modulation of presynaptic dopaminergic neurotransmission: role of D2 dopamine autoreceptors.
Leo D; Mus L; Espinoza S; Hoener MC; Sotnikova TD; Gainetdinov RR
Neuropharmacology; 2014 Jun; 81():283-91. PubMed ID: 24565640
[TBL] [Abstract][Full Text] [Related]
11. Trace amine-associated receptor 1 is a modulator of the dopamine transporter.
Xie Z; Miller GM
J Pharmacol Exp Ther; 2007 Apr; 321(1):128-36. PubMed ID: 17234899
[TBL] [Abstract][Full Text] [Related]
12. Selective transport of monoamine neurotransmitters by human plasma membrane monoamine transporter and organic cation transporter 3.
Duan H; Wang J
J Pharmacol Exp Ther; 2010 Dec; 335(3):743-53. PubMed ID: 20858707
[TBL] [Abstract][Full Text] [Related]
13. Studies of the biogenic amine transporters. 14. Identification of low-efficacy "partial" substrates for the biogenic amine transporters.
Rothman RB; Partilla JS; Baumann MH; Lightfoot-Siordia C; Blough BE
J Pharmacol Exp Ther; 2012 Apr; 341(1):251-62. PubMed ID: 22271821
[TBL] [Abstract][Full Text] [Related]
14. Trace amine-associated receptor 1 as a monoaminergic modulator in brain.
Xie Z; Miller GM
Biochem Pharmacol; 2009 Nov; 78(9):1095-104. PubMed ID: 19482011
[TBL] [Abstract][Full Text] [Related]
15. Modafinil occupies dopamine and norepinephrine transporters in vivo and modulates the transporters and trace amine activity in vitro.
Madras BK; Xie Z; Lin Z; Jassen A; Panas H; Lynch L; Johnson R; Livni E; Spencer TJ; Bonab AA; Miller GM; Fischman AJ
J Pharmacol Exp Ther; 2006 Nov; 319(2):561-9. PubMed ID: 16885432
[TBL] [Abstract][Full Text] [Related]
16. MDMA (Ecstasy) and human dopamine, norepinephrine, and serotonin transporters: implications for MDMA-induced neurotoxicity and treatment.
Verrico CD; Miller GM; Madras BK
Psychopharmacology (Berl); 2007 Jan; 189(4):489-503. PubMed ID: 16220332
[TBL] [Abstract][Full Text] [Related]
17. Cloning, expression, and functional analysis of rhesus monkey trace amine-associated receptor 6: evidence for lack of monoaminergic association.
Xie Z; Vallender EJ; Yu N; Kirstein SL; Yang H; Bahn ME; Westmoreland SV; Miller GM
J Neurosci Res; 2008 Nov; 86(15):3435-46. PubMed ID: 18627029
[TBL] [Abstract][Full Text] [Related]
18. Biogenic amine flux mediated by cloned transporters stably expressed in cultured cell lines: amphetamine specificity for inhibition and efflux.
Wall SC; Gu H; Rudnick G
Mol Pharmacol; 1995 Mar; 47(3):544-50. PubMed ID: 7700252
[TBL] [Abstract][Full Text] [Related]
19. Regulation of monoamine transporters: Role of transporter phosphorylation.
Ramamoorthy S; Shippenberg TS; Jayanthi LD
Pharmacol Ther; 2011 Feb; 129(2):220-38. PubMed ID: 20951731
[TBL] [Abstract][Full Text] [Related]
20. Dopamine uptake through the norepinephrine transporter in brain regions with low levels of the dopamine transporter: evidence from knock-out mouse lines.
Morón JA; Brockington A; Wise RA; Rocha BA; Hope BT
J Neurosci; 2002 Jan; 22(2):389-95. PubMed ID: 11784783
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
